Inflammation in hypertension: current therapeutic approaches.

Current pharmaceutical design

Volumn 17, Issue 37, 2011, Pages 4121-4131

  Androulakis, Emmanuel ^a   Tousoulis, Dimitris ^b   Papageorgiou, Nikolaos ^b   Latsios, George ^b   Siasos, Gerasimos ^b   Tsioufis, Costas ^b   Giolis, Anastasios ^b   Stefanadis, Christodoulos ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; AUTACOID; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; CYCLOOXYGENASE 2 INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE;

ADIPOSE TISSUE; ANIMAL; BLOOD; DRUG COMBINATION; HUMAN; HYPERTENSION; IMMUNOLOGY; INFLAMMATION; METABOLISM; REVIEW; VASCULAR ENDOTHELIUM;

ADIPOSE TISSUE; ALDOSTERONE; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CYCLOOXYGENASE 2 INHIBITORS; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; INFLAMMATION; INFLAMMATION MEDIATORS; NF-KAPPA B; REACTIVE OXYGEN SPECIES;

MLCS; MLOWN;

EID: 84861302956     PISSN: None     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211798764753     Document Type: Review

References (0)